INFLAMMATORY AND ELECTROPHYSIOLOGICAL PREDICTORS OF ATRIAL FIBRILLATION PROGRESSION IN PATIENTS WITH CARDIOVASCULAR DISEASE

Authors

  • Kasimov Khabib Khamidovich Department of Medicine, Faculty of Medicine, University of Business and Science
  • Kasimov Bokirali Khakimovich Department of Medicine, Faculty of Medicine, University of Business and Science
  • Inomov Kamoliddin Mamasoli ugli Department of Medicine, Faculty of Medicine, University of Business and Science

DOI:

https://doi.org/10.5281/zenodo.20208497

Keywords:

atrial fibrillation, arrhythmia, inflammation, CRP, electrophysiology, cardiovascular disease

Abstract

Atrial fibrillation (AF) is one of the most common cardiac arrhythmias associated with increased morbidity, thromboembolic complications, and mortality. Recent evidence indicates that inflammatory activation and structural myocardial remodeling play a central role in AF progression. The present study aimed to evaluate inflammatory and electrophysiological predictors of atrial fibrillation progression in patients with cardiovascular disease. The study included 52 patients with documented AF who underwent electrocardiographic, echocardiographic, and biochemical evaluation. Elevated C-reactive protein (CRP), left atrial enlargement, and prolonged P-wave duration were significantly associated with recurrent arrhythmic episodes and worsening clinical status. Statistical analysis demonstrated a strong positive correlation between CRP levels and AF recurrence frequency (r = 0.71; p <0.001), while left atrial diameter negatively correlated with sinus rhythm maintenance (r = –0.64; p <0.01). The findings confirm the prognostic importance of inflammatory and electrophysiological abnormalities in atrial fibrillation progression.

Downloads

Download data is not yet available.

References

1.Hindricks G., et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. European Heart Journal. 2021;42(5):373–498.

2.Hu Y.F., et al. Inflammation and the pathogenesis of atrial fibrillation. Nature Reviews Cardiology. 2015;12(4):230–243.

3.Aviles R.J., et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–3010.

4.January C.T., et al. AHA/ACC/HRS guideline for atrial fibrillation management. Circulation. 2019;140(2):e125–e151.

5.Kotecha D., Piccini J.P. Atrial fibrillation in heart failure. European Heart Journal. 2015;36(46):3250–3257.

Downloads

Published

2026-05-15

How to Cite

INFLAMMATORY AND ELECTROPHYSIOLOGICAL PREDICTORS OF ATRIAL FIBRILLATION PROGRESSION IN PATIENTS WITH CARDIOVASCULAR DISEASE. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(5), 1023-1025. https://doi.org/10.5281/zenodo.20208497

Similar Articles

1-10 of 446

You may also start an advanced similarity search for this article.